Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
July 09, 2025 16:16 ET Â | Source: Rhythm Pharmaceuticals, Inc. BOSTON, July…
Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance
ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) -- Ascentage…
VivoPower Commences $29 Million Shareholder Loan Financing Retirement Plan
LONDON, July 07, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (Nasdaq: VVPR)…
HOTEL101 GLOBAL RECEIVES APPROVAL TO LIST ON NASDAQ UNDER “HBNB”
Celebrated Public Listing by Ringing the Opening Bell Today at the Nasdaq…
Bybit TradFi x Crypto Report: Regulatory Tailwinds Drive Coinbase Outperformance Despite Premium Valuation
DUBAI, UAE, July 4, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency…
Radware Schedules Conference Call for Its Second Quarter 2025 Earnings
TEL AVIV, Israel, July 02, 2025 (GLOBE NEWSWIRE) -- Radware® (NASDAQ: RDWR),…
The Ensign Group, Inc. Announces Retirement of Its Executive Chairman
June 20, 2025 16:30 ET Â | Source: The Ensign Group, Inc. SAN…
Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders
June 20, 2025 17:00 ET Â | Source: Inozyme Pharma Inc. BOSTON, June…
SINOVAC Board of Directors Prevails Against Advantech/Primes New York Lawsuit
New York Court Denies Advantech/Prime’s Petition for Emergency Injunctive Relief Clears Legal…
Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671
June 20, 2025 19:30 ET Â | Source: Structure Therapeutics Inc. SAN FRANCISCO,…